Ovarian Cancer
Showing NaN - NaN of 110
Ovarian Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Tumors Trial in Worldwide (biological, drug, other)
Recruiting
- Ovarian Cancer
- +2 more
- Pembrolizumab
- +4 more
-
Phoenix, Arizona
- +178 more
Jan 25, 2023
Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)
Recruiting
- Advanced Malignancies
- +4 more
- Avelumab
- +7 more
-
Fayetteville, Arkansas
- +61 more
Jan 10, 2023
NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)
Recruiting
- Non-small Cell Lung Cancer
- +11 more
-
Birmingham, Alabama
- +32 more
Jan 4, 2023
Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))
Completed
- Ovarian Cancer
- +7 more
- Enapotamab vedotin (HuMax-AXL-ADC)
-
Phoenix, Arizona
- +40 more
Dec 12, 2022
Ovarian Cancer Trial in Worldwide (VS-6766, VS-6766 and Defactinib)
Recruiting
- Low Grade Ovarian Serous Adenocarcinoma
- Ovarian Cancer
- avutometinib (VS-6766)
- avutometinib (VS-6766) and Defactinib
-
Scottsdale, Arizona
- +46 more
Dec 29, 2022
Biliary Tract Cancer (BTC), Colorectal Cancer (CRC), Endometrial Cancer Trial in Belgium, United Kingdom, United States
Completed
- Biliary Tract Cancer (BTC)
- +5 more
- INCB001158
- +6 more
-
Birmingham, Alabama
- +9 more
Dec 22, 2022
Ovarian Cancer Trial in Worldwide (AZD2281, matching )
Active, not recruiting
- Ovarian Cancer
- AZD2281
- matching placebo
-
Berkeley, California
- +73 more
Dec 19, 2022
Investigate Adaptation and Evolution of Ovarian High-grade
Recruiting
- Ovarian Cancer
- +6 more
-
Bristol, United Kingdom
- +10 more
Sep 8, 2022
Ovarian Epithelial Cancer, Carcinoma in Situ, Ovarian Cancer Trial in Worldwide (Lavage of the Cavum uteri and proximal
Completed
- Ovarian Epithelial Cancer
- +2 more
- Lavage of the Cavum uteri and proximal Fallopian tubes, performed in the luteal phase of the female cycle
-
Graz, Austria
- +13 more
Sep 1, 2022
Ovarian Cancer, Breast Cancer Trial in Worldwide (Olaparib)
Enrolling by invitation
- Ovarian Cancer
- Breast Cancer
-
Boca Raton, Florida
- +98 more
Aug 22, 2022
Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)
Active, not recruiting
- Advanced Solid Tumors
- +7 more
- Pembrolizumab
- Lenvatinib
-
Duarte, California
- +87 more
Aug 19, 2022
Melanoma, Breast Cancer, Uterine Cancer Trial in London (MRx0518 Capsules, MRx0518/ Capsules)
Active, not recruiting
- Melanoma
- +9 more
- MRx0518 Capsules
- MRx0518/placebo Capsules
-
London, United KingdomImperial College Healthcare NHS Trust
Aug 10, 2022
Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan
Not yet recruiting
- Endometrial Cancer
- +4 more
- Datopotamab deruxtecan (Dato-DXd)
- +8 more
-
Los Angeles, California
- +52 more
Aug 3, 2022
Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)
Recruiting
- Ovarian Cancer
- +10 more
-
West Hollywood, California
- +27 more
Jun 27, 2022
Prostate Cancer, Non Small Cell Lung Cancer, Ovarian Cancer Trial in London, Oxford (OVM-200)
Recruiting
- Prostate Cancer
- +2 more
- OVM-200
-
London, United Kingdom
- +2 more
Apr 26, 2022